本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Forte BioSciences Inc

13.66
-0.1800-1.30%
盘后13.660.00000.00%16:40 EDT
成交量:2.37万
成交额:32.96万
市值:1.67亿
市盈率:-1.66
高:14.49
开:13.84
低:13.35
收:13.84
数据加载中...
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/21

重要事件披露

Form 8-K - Current report
2023/09/21

重要事件披露

Form 8-K - Current report
2023/09/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/06

SEC问询函

Form CORRESP - Correspondence
2023/08/30

SEC问询函

Form CORRESP - Correspondence
2023/08/24

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/08/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/02

重要事件披露

Form 8-K - Current report
2023/07/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]